Effect of ramipril on endothelial dysfunction in patients with essential hypertension

Clinical Drug Investigation

Volumn 22, Issue 7, 2002, Pages 449-453

  Fang, Li ^a   Zheng, Fang ^b   Qingyin, Tian ^a   Ming, Zhong ^a   Yanyan, Hu ^a  

^a SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; NITRENDIPINE; RAMIPRIL;

ADULT; ARTERY DIAMETER; ARTICLE; BRACHIAL ARTERY; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULTRASOUND; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0036062416     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222070-00005     Document Type: Article

References (20)

1. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension
2. The endothelium in hypertension: Bystander, target or mediator?
3. Role of endothelial dysfunction in coronary artery disease
4. Coronary risk factors, endothelial function and atherosclerosis: A review
5. Effect of captopril and enalapril on endothelial function in hypertensive patients
6. Effect of cilazapril on vascular structure and function in essential hypertension
7. Effect of lisinopril on endothelial function
8. Effect of anti-hypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension
9. Effect of enalapril and quinapril on forearm vascular ACE in man
10. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension
11. The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not
12. Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans
13. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans
14. Management of hypertension and its sequelae with ACE inhibitors: Biochemical, pharmacological and clinical aspects
15. Physicochimical and enzyme binding kinetic properties of a new angiotension-converting enzyme inhibitor ramipril and their clinical implications
16. Ramipril: Review of pharmacology
17. Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins
18. Ramipril therapy improves arterial dilation in experimental hypertension
19. Measurement of endothelial function by brachial artery flow-mediated vasodilation
20. Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility